According to Armata Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.03. In 2022 the company made an earnings per share (EPS) of -$1.09 a decrease over its 2021 EPS that were of -$0.97.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.03 | -5.5% |
2022 | -$1.09 | 12.37% |
2021 | -$0.97 | -31.69% |
2020 | -$1.42 | -44.75% |
2019 | -$2.57 | -49.67% |
2018 | -$5.11 | -88.88% |
2017 | -$45.92 | -87.24% |
2016 | -$359.94 | -15.98% |
2015 | -$428.40 | -171.33% |
2014 | $600.60 | -115.32% |
2013 | -$3,920 | |
2008 | -$7,210 | 0.98% |
2007 | -$7,140 | -69.82% |
2006 | -$23,660 | 57.21% |
2005 | -$15,050 | 19.44% |
2004 | -$12,600 | 869.22% |
2003 | -$1,300 | -50.94% |
2002 | -$2,650 | -14.52% |
2001 | -$3,100 |